Early Intervention for Asthma Prevention in Children
The last few decades have seen a global rise in asthma prevalence. In the United States, based on the National Health Interview Survey sample in 1998, the National Center for Health Statistics determined that asthma was the most commonly diagnosed chronic disease of childhood, with 12.1% or 8.65 million U.S. children reported as being diagnosed with asthma in their lifetime. As a result, asthma pathogenesis has received much attention, with the hope of reversing this concerning global trend by developing new approaches to asthma prevention. Current evidence suggests that most childhood asthma begins in the early years. In addition, early pathogenic development of the immune systems and lungs of children with asthma suggests that the early years may be the best time for preventive intervention. To consider intervention for asthma in early childhood (i.e., in the first 6 years of life), we will discuss (1) childhood risk factors for chronic persistent asthma, (2) early pathogenic changes in asthma, (3) potential pharmacologic and nonpharmacologic interventions for the young asthma-prone child, and (4) potential future immune modulatory therapies and prevention.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
Document Type: Research Article
Publication date: 2002-09-01
More about this publication?
- Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.
The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
- Editorial Board
- Information for Authors
- Submit a Paper
- Information for Advertisers
- Reprint Requests
- Ingenta Connect is not responsible for the content or availability of external websites